VALERIO THERAPEUTICS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1114 EUR | +1.27% |
|
-4.13% | -32.48% |
| 2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Chart calendar Valerio Therapeutics
497844be2165ac94.b4fqMjvDvogA9QkIDJ0phNvdX88rli3huYr0Em8L_-4.DeyddhaRjcdJslx6Ve5I_I-8OIZdrnityeakVhlkpZYF1LMKaID20Ea0UA~13c692b2d7258b7b13c97cd7ec3705aa
Upcoming events on Valerio Therapeutics
Past events on Valerio Therapeutics
| 28/09/2023 11:43 pm | Q2 2023 Earnings Release |
| 06/06/2023 05:30 pm | Annual General Meeting |
| 24/04/2023 11:41 pm | Q4 2022 Earnings Release |
| 06/02/2023 | Extraordinary Shareholders Meeting |
| 13/09/2022 11:00 pm | Interim 2022 Earnings Release |
| 17/08/2022 05:30 pm | Shareholders Meeting |
| 15/06/2022 06:00 pm | Annual General Meeting |
| 12/05/2022 | Shareholders Meeting |
| 19/04/2022 05:30 pm | Extraordinary Shareholders Meeting |
| 12/04/2022 06:30 pm | American Association of Cancer Research Meeting - Oral No. PO.ET04.02 |
| 11/04/2022 01:05 am | American Association of Cancer Research Meeting - Oral No. MS.ET03.01 |
| 08/04/2022 | American Association of Cancer Research Meeting |
| 07/04/2022 | FY 2021 Earnings Release After hours |
| 08/12/2021 10:30 pm | European Association for Cancer Research and AstraZeneca - AsiDNA tackles Drug-tolerant persister ce |
| 13/09/2021 | H.C. Wainwright Global Investment Conference |
| 29/07/2021 10:00 pm | Interim 2021 Earnings Release |
| 21/06/2021 | Kepler Cheuvreux & Belfius Digital Life Science Days |
| 11/06/2021 | BIO International Conference |
| 10/06/2021 06:30 pm | Annual General Meeting |
| 12/05/2021 | Shareholders Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 6,13 3,35 82.9% | 4,29 3,30 29.97% | 1,78 1,69 5.21% | 4,06 0,00 - |
|
EBITDA Million EUR | Released Forecast Spread | -2,99 -7,20 58.53% | -9,12 -11,4 19.66% | 2,81 -5,10 155.13% | -4,68 -10,1 53.81% |
|
EBIT Million EUR | Released Forecast Spread | -15,6 -16,5 4.99% | -34,3 -11,9 -188.64% | 2,19 -5,77 138.01% | -5,14 -10,8 52.35% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -11,2 -16,5 32.24% | -36,1 -11,9 -202.98% | 1,85 -6,21 129.73% | -5,84 -10,8 45.94% |
|
Net income Million EUR | Released Forecast Spread | -9,40 -14,8 36.31% | -33,7 -11,9 -183.45% | 1,09 -5,33 120.45% | -5,94 -10,8 45% |
|
EPS EUR | Released Forecast Spread | -0,18 -0,29 37.93% | -0,55 -0,22 -150% | 0,01 -0,08 112.5% | -0,07 -0,14 50% |
| Announcement Date | 12/03/19 | 17/04/20 | 21/04/21 | 06/04/22 |
More events
Past sector events for Valerio Therapeutics
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVIO Stock
- Calendar Valerio Therapeutics
